Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Marianne Pavel
ResearcherPublications, citations & collaboration network
Marianne Pavel is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 208 works, 15,559 citations, an h-index of 38 and an i10-index of 79.
208
Works
15,559
Citations
38
h-index
79
i10-index
IDs:OpenAlex
How has Marianne Pavel's publication output changed over time?
ScholarIQpublication output · 2009–2020
Output grew0% over the shown period — from 1 works in 2009 to 1 in 2020.
1
4
1
2
1
1
1
2009201120142015201620172020
What are the most-cited papers on Marianne Pavel?
ScholarIQmost cited works
Everolimus for Advanced Pancreatic Neuroendocrine Tumors
James C. Yao, Manisha H. Shah, Tetsuhide Ito, C. Lombard Bohas, Edward M. Wolin, Eric Van Cutsem, Timothy J. Hobday, Takuji Okusaka, Jaume Capdevila, Elisabeth G.E. de Vries, Paola Tomassetti, Marianne Pavel, Sakina Hoosen, T Haas, Jeremie Lincy, David Lebwohl, Kjell Öberg
New England Journal of Medicine. 20112,863 CitationsOPEN ACCESS
Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors
Martyn Caplin, Marianne Pavel, Jarosław B. Ćwikła, Alexandria T. Phan, Markus Raderer, Eva Sedláčková, Guillaume Cadiot, Edward M. Wolin, Jaume Capdevila, Lucy Wall, Guido Rindi, Alison Langley, Séverine Martinez, Joëlle Blumberg, Philippe Ruszniewski
New England Journal of Medicine. 20141,935 CitationsOPEN ACCESS
Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study
James C. Yao, Nicola Fazio, Simron Singh, Roberto Buzzoni, Carlo Carnaghi, Edward M. Wolin, Jiří Tomášek, Markus Raderer, Harald Lahner, Maurizio Voi, Lida Pacaud, Nicolas Rouyrre, Carolin Sachs, Juan W. Valle, Gianfranco Delle Fave, Eric Van Cutsem, Margot Tesselaar, Yasuhiro Shimada, Do‐Youn Oh, Jonathan Strosberg, Matthew H. Kulke, Marianne Pavel
The Lancet. 20151,272 Citations
Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Marianne Pavel, Kjell Öberg, M. Falconi, E. P. Krenning, Anders Sundin, Aurel Perren, Alfredo Berruti
Annals of Oncology. 20201,166 CitationsOPEN ACCESS
Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study
Marianne Pavel, John D. Hainsworth, Éric Baudin, Marc Peeters, Dieter Hörsch, Robert Winkler, Judith Klimovsky, David Lebwohl, Valentine Jehl, Edward M. Wolin, Kjell Öberg, Eric Van Cutsem, James C. Yao
The Lancet. 20111,054 Citations
Related on ScholarIQ
Friedrich-Alexander-Universität Erlangen-Nürnberg
Institution
Everolimus for Advanced Pancreatic Neuroendocrine Tumors
Paper
Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors
Paper
Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study
Paper
Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Paper
Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study
Paper